Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.22%

Agenus Inc. (AGEN)

-NasdaqCM
7.62 Down 0.20(2.56%) 4:00PM EDT
|After Hours : 7.62 Down 0.01 (0.13%) 4:00PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:7.82
Open:7.90
Bid:7.62 x 10000
Ask:7.63 x 4500
1y Target Est:10.00
Beta:0.16
Earnings Date:Jul 22 - Jul 27 (Est.)
Day's Range:7.53 - 8.09
52wk Range:2.56 - 8.09
Volume:2,532,525
Avg Vol (3m):1,419,210
Market Cap:544.72M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AGENDown 2.56%544.72M
ABPI 0.00%N/A
DNDN 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):54.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.78
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback